Corticosteroid Pulse Combination Therapy for Refractory Kawasaki Disease: A Randomized Trial
暂无分享,去创建一个
M. Ishii | Shohei Ogata | Shohei Ogata | Yoshihito Ogihara | Takashi Honda | Shinya Kon | Kazumasa Akiyama | Masahiro Ishii | Yoshihito Ogihara | T. Honda | Kazumasa Akiyama | S. Kon
[1] S. Koike,et al. Kawasaki disease: effect of treatment on coronary artery involvement. , 1979, Pediatrics.
[2] J. Newburger,et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. , 2008, The Journal of pediatrics.
[3] Kei Takahashi,et al. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[4] Kayoko Sato,et al. Clinical Score and Transcript Abundance Patterns Identify Kawasaki Disease Patients Who May Benefit From Addition of Methylprednisolone , 2009, Pediatric Research.
[5] S. Kurotobi,et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment , 2006, European Journal of Pediatrics.
[6] M. Ishii,et al. Re‐treatment for immune globulin‐resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapy , 2001, Pediatrics international : official journal of the Japan Pediatric Society.
[7] Yoshikazu Nakamura,et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) , 2005, Pediatrics international : official journal of the Japan Pediatric Society.
[8] H. Yanagawa,et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.
[9] C. Doig,et al. Targeting Adhesion Molecules as a Potential Mechanism of Action for Intravenous Immunoglobulin , 2005, Circulation.
[10] S. Colan,et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. , 1998, The Journal of pediatrics.
[11] R. Clynes. IVIG Therapy: Interfering with Interferon-γ , 2007 .
[12] Y. Kohno,et al. Prognostic Impact of Vascular Leakage in Acute Kawasaki Disease , 2003, Circulation.
[13] Y. Niwa,et al. Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. , 1984, The Journal of pediatrics.
[14] T. Matsuishi,et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.
[15] Y. Yamashiro,et al. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease , 2007, Archives of Disease in Childhood.
[16] J. Newburger,et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. , 1996, The Journal of pediatrics.
[17] M. Ishii,et al. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. , 2009, Journal of cardiology.
[18] Walter R Wilson,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Circulation.
[19] Tomio Kobayashi,et al. Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.
[20] S. Colan,et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. , 2011, The Journal of pediatrics.
[21] J. Newburger,et al. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. , 2003, The Journal of pediatrics.
[22] J. Abe,et al. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease. , 2008, The Journal of allergy and clinical immunology.
[23] J. Newburger,et al. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. , 1998, The Pediatric infectious disease journal.
[24] Paul D Mitchell,et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. , 2007, The New England journal of medicine.
[25] M. Satoh,et al. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin , 2008, European Journal of Pediatrics.
[26] T. Sano,et al. Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki disease , 2009, European Journal of Pediatrics.